Treatment of AL amyloidosis with high dose therapy and autologous stem cell transplantation.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 16840183)

Published in Leuk Lymphoma on June 01, 2006

Authors

Meletios A Dimopoulos¹

Author Affiliations

1: Department of Clinical Therapeutics, University of Athens, School of Medicine, Athens, Greece. mdimop@med.uoa.gr

Articles cited by this ↗

Autologous stem cell transplantation and IgM amyloidosis. Leuk Lymphoma (2006) 1.38

Articles by these authors ⇆

Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myeloma. Haematologica (2007) 0.84

Proteasome inhibitor therapy for Waldenström's macroglobulinemia. Clin Lymphoma Myeloma Leuk (2013) 0.80

High dose therapy with autologous stem cell transplantation for solitary bone plasmacytoma complicated by local relapse or isolated distant recurrence. Leuk Lymphoma (2003) 0.78